Furthermore, bycarefully examining luminal breast cancer cases with RUNX1mutations, we noticed that >50% of them are accompanied by mutations ordeletions in either TP53 or RB1 genes (Cancer Genome Atlas Network, 2012). This evidence concerns the gene TP53 and breast carcinoma.